2017
DOI: 10.1016/j.lfs.2017.09.030
|View full text |Cite
|
Sign up to set email alerts
|

Chronic low-dose glucocorticoid treatment increases subcutaneous abdominal fat, but not visceral fat, of male Wistar rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
5
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 34 publications
1
5
0
Order By: Relevance
“…However, in both in vivo studies, these results were not compared to those in subcutaneous WAT. Others have demonstrated that there are differential sensitivities of subcutaneous and visceral depots in rats treated with high or low doses of corticoids ( Nunes et al, 2017 ). At low doses, only subcutaneous fat depots had increased their lipid storage capability and activity of lipid synthesising enzymes while these parameters were increased in visceral fat at high doses ( Nunes et al, 2017 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, in both in vivo studies, these results were not compared to those in subcutaneous WAT. Others have demonstrated that there are differential sensitivities of subcutaneous and visceral depots in rats treated with high or low doses of corticoids ( Nunes et al, 2017 ). At low doses, only subcutaneous fat depots had increased their lipid storage capability and activity of lipid synthesising enzymes while these parameters were increased in visceral fat at high doses ( Nunes et al, 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…Others have demonstrated that there are differential sensitivities of subcutaneous and visceral depots in rats treated with high or low doses of corticoids ( Nunes et al, 2017 ). At low doses, only subcutaneous fat depots had increased their lipid storage capability and activity of lipid synthesising enzymes while these parameters were increased in visceral fat at high doses ( Nunes et al, 2017 ). Another study confirmed genetic and metabolic differences between subcutaneous and visceral locations at the level of the corresponding adipose-derived stem cells using gene expression analysis ( Kim et al, 2016 ).…”
Section: Discussionmentioning
confidence: 99%
“…[49][50][51] In addition, it is also known that glucocorticoid-induced redistribution in adipose tissue may be considered a form of iatrogenic lipodystrophy. It is well known that oral glucocorticoids drugs are associated with abnormal deposits in abdominal subcutaneous adipose tissue, and a recent experimental study showed that, even at chronic low-doses, this pattern occurs.…”
Section: Discussionmentioning
confidence: 99%
“…It is well known that oral glucocorticoids drugs are associated with abnormal deposits in abdominal subcutaneous adipose tissue, and a recent experimental study showed that, even at chronic low-doses, this pattern occurs. [49][50][51] In addition, it is also known that glucocorticoid-induced redistribution in adipose tissue may be considered a form of iatrogenic lipodystrophy. 52 According to Pickering by which dexamethasone could promote the preferential storage of fat in visceral deposits.…”
Section: Considering This Difference Between Groups and The Differencmentioning
confidence: 99%
“…At high doses, GCs increase lipolysis, antagonize the lipolytic effect of insulin, and increase appetite. GCs increase protein synthesis in the liver but inhibit it in other tissues (7)(8)(9)(10).…”
Section: Introductionmentioning
confidence: 99%